Back to list

OPN

Operator of a full-featured payment management platform intended to connect millions of customers across the world.
Operator of a full-featured payment management platform intended to connect millions of customers across the world.
Other Healthcare Services 📍 Glendale, CA Founded 1999
Current Valuation
$1.0B
as of 2022-Q2
UNICORN

QL Price

$1.0B
0% vs last round
QuantLogix's current estimate for OPN, published 2026-09-09 — in line with the last disclosed round of $1.0B (2022-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round $1.0B 2022-Q2 weight 0.05
Secondary market print $1.0B 2026-06-27 weight 0.64
How this price has held up
No round has priced for OPN since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-09 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to OPN →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, OPN, 2026-09-09 (4419e465a15a0673). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is OPN going public?
No. OPN is private and has not filed to go public. There is no S-1 on file.
What is OPN's valuation in 2026?
OPN is valued at $1.0B as of 2022-Q2, set by its Series C ($120M, May 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has OPN filed an S-1?
No public S-1 is on file for OPN.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

Founded
1999
HQ
Glendale, CA
Employees
34
Total Raised
$260.5M
Last Round
Series C — $120M (May 2022)
IPO Status
private

Fundraising Status

Series C · $120M · 4y 4mo ago
privateTotal raised $260.5M

Secondary Market

Implied price / share
$200
Secondary price return by period
Secondary market period returns3-month0.0%6-month0.0%1-year0.0%All-time0.0%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series C$120MMay 2022$1.0B

Talent Signal

Hiring trend
First snapshot
trend accrues with monthly sweeps
Open roles
6
via careers page
Product-build share
67%
engineering, research, product, design
Trajectory
steady
heavy product build — 67% of open roles are product-building functions (engineering/research/product) — 4 of 6 open roles are medical.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by month6Aug '26
Open roles by function
Open roles by functionClinical & Science4Support2
product-building   go-to-market / G&A
Clinical TrialsActive Clinical Trials[Clinical Trials](https://opnhc.com/platform/clinical-trials/)[Clinical Trials](https://opnhc.com/careers)Patient Support[Patient Support](https://opnhc.com/alignment/patient-support/)
Counted from OPN's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
FinTechBlockchainFinancial ServicesPayments
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q2. Refreshed quarterly.